AlloBiotech

AlloBiotech is a medical device company developing next‑generation silicone breast implants engineered for enhanced biocompatibility, durability, and long‑term safety. By addressing the root causes of implant failure—such as capsular contracture and mechanical degradation—AlloBiotech aims to reduce complications, minimize reoperations, and lower the lifetime burden of care, bringing much‑needed innovation back to women’s health and improving outcomes for patients and surgeons alike.